Literature DB >> 7638213

Older plasma lipoproteins are more susceptible to oxidation: a linking mechanism for the lipid and oxidation theories of atherosclerotic cardiovascular disease.

R L Walzem1, S Watkins, E N Frankel, R J Hansen, J B German.   

Abstract

Increases in plasma cholesterol are associated with progressive increases in the risk of atherosclerotic cardiovascular disease. In humans plasma cholesterol is contained primarily in apolipoprotein B-based low density lipoprotein (LDL). Cells stop making the high-affinity receptor responsible for LDL removal as they become cholesterol replete; this slows removal of LDL from plasma and elevates plasma LDL. As a result of this delayed uptake, hypercholesterolemic individuals not only have more LDL but have significantly older LDL. Oxidative modification of LDL enhances their atherogenicity. This study sought to determine whether increased time spent in circulation, or aging, by lipoprotein particles altered their susceptibility to oxidative modification. Controlled synchronous production of distinctive apolipoprotein B lipoproteins (yolk-specific very low density lipoproteins; VLDLy) with a single estrogen injection into young turkeys was used to model LDL aging in vivo. VLDLy remained in circulation for at least 10 days. Susceptibility to oxidation in vitro was highly dependent on lipoprotein age in vivo. Oxidation, measured as hexanal release from n-6 fatty acids in VLDLy, increased from 13.3 +/- 5.5 nmol of 2-day-old VLDLy per ml, to 108 +/- 17 nmol of 7-day-old VLDLy per ml. Oxidative instability was not due to tocopherol depletion or conversion to a more unsaturated fatty acid composition. These findings establish mathematically describable linkages between the variables of LDL concentration and LDL oxidation. The proposed mathematical models suggest a unified investigative approach to determine the mechanisms for acceleration of atherosclerotic cardiovascular disease risk as plasma cholesterol rises.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7638213      PMCID: PMC41359          DOI: 10.1073/pnas.92.16.7460

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

2.  Temperature and hydrostatic pressure-dependent pathways of low-density lipoprotein transport across microvascular barrier.

Authors:  J C Rutledge
Journal:  Am J Physiol       Date:  1992-01

3.  Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation.

Authors:  B Frei; J M Gaziano
Journal:  J Lipid Res       Date:  1993-12       Impact factor: 5.922

4.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

5.  Quantitative effects of dietary fat on serum cholesterol in man.

Authors:  D M Hegsted; R B McGandy; M L Myers; F J Stare
Journal:  Am J Clin Nutr       Date:  1965-11       Impact factor: 7.045

6.  Coordinate regulation of two estrogen-dependent genes in avian liver.

Authors:  R Wiskocil; P Bensky; W Dower; R F Goldberger; J I Gordon; R G Deeley
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

7.  Pathways for the incorporation of esterified cholesterol into very low density and low density lipoproteins in plasma incubated in vitro.

Authors:  P J Barter; G J Hopkins; G D Calvert
Journal:  Biochim Biophys Acta       Date:  1982-10-14

8.  Regulation of low-density lipoprotein receptors: implications for pathogenesis and therapy of hypercholesterolemia and atherosclerosis.

Authors:  J L Goldstein; M S Brown
Journal:  Circulation       Date:  1987-09       Impact factor: 29.690

9.  A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits.

Authors:  J Fruebis; D Steinberg; H A Dresel; T E Carew
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

10.  Determination of lipid hydroperoxides in native low-density lipoprotein by a chemiluminescent flow-injection assay.

Authors:  L Cominacini; A M Pastorino; A McCarthy; M Campagnola; U Garbin; A Davoli; A De Santis; V Lo Cascio
Journal:  Biochim Biophys Acta       Date:  1993-01-10
View more
  7 in total

1.  Lipoproteins: When size really matters.

Authors:  J Bruce German; Jennifer T Smilowitz; Angela M Zivkovic
Journal:  Curr Opin Colloid Interface Sci       Date:  2006-06       Impact factor: 6.448

Review 2.  Oxidative stress--implications, source and its prevention.

Authors:  Rajbir Kaur; Jasmit Kaur; Jyoti Mahajan; Rakesh Kumar; Saroj Arora
Journal:  Environ Sci Pollut Res Int       Date:  2013-10-30       Impact factor: 4.223

3.  Chungtaejeon, a Korean fermented tea, scavenges oxidation and inhibits cytokine induced proliferation and migration of human aortic smooth muscle cells.

Authors:  Rajendra Karki; Navin Sahi; Eun-Raye Jeon; Yong-Seo Park; Dong-Wook Kim
Journal:  Plant Foods Hum Nutr       Date:  2011-03       Impact factor: 3.921

Review 4.  Dyslipoproteinemia and impairment of renal function in diabetic kidney disease: an analysis of animal studies, observational studies, and clinical trials.

Authors:  Chi-Chih Hung; Jer-Chia Tsai; Hung-Tien Kuo; Jer-Ming Chang; Shang-Jyh Hwang; Hung-Chun Chen
Journal:  Rev Diabet Stud       Date:  2013-08-10

5.  Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100.

Authors:  M M Véniant; M A Sullivan; S K Kim; P Ambroziak; A Chu; M D Wilson; M K Hellerstein; L L Rudel; R L Walzem; S G Young
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

6.  Inhibitory effect on in vitro LDL oxidation and HMG Co-A reductase activity of the liquid-liquid partitioned fractions of Hericium erinaceus (Bull.) Persoon (lion's mane mushroom).

Authors:  Mohammad Azizur Rahman; Noorlidah Abdullah; Norhaniza Aminudin
Journal:  Biomed Res Int       Date:  2014-05-13       Impact factor: 3.411

7.  Oxidative Modification of LDL by Various Physicochemical Techniques: Its Probable Role in Diabetes Coupled with CVDs.

Authors:  Sultan Alouffi; Mohammad Faisal; Abdulrahman A Alatar; Saheem Ahmad
Journal:  Biomed Res Int       Date:  2018-11-18       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.